# BCLI (Brainstorm Cell Therapeutics Inc.) - SEC EDGAR Financial Statements

> Brainstorm Cell Therapeutics Inc. reported $840K in total assets and a net loss of $10.15M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BCLI
- Markdown: https://convexityos.com/fundamentals/BCLI.md
- SEC CIK: 0001137883
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001137883&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$9.52M | Operating profit |
| Net Income | FY 2025 | -$10.15M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.85 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $163K | Total debt: $1.93M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $4.17M | $4.65M | $10.75M | $13.96M | $15.23M | $22.33M | $17.20M | $8.29M | $977K | $2.25M |
| **Operating Income** | -$9.95M | -$11.69M | -$21.44M | -$24.82M | -$24.54M | -$31.68M | -$23.00M | -$14.06M | -$5.00M | -$5.08M |
| **EBITDA** | -$9.75M | -$11.45M | -$21.17M | -$24.54M | -$24.28M | -$31.46M | -$22.84M | -$13.95M | -$4.91M | -$5.01M |
| Income Before Tax | -$10.31M | -$11.62M | -$17.19M | -$24.28M | -$24.46M | -$31.81M | -$23.25M | -$13.95M | -$4.95M | -$4.98M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Net Income** | -$10.31M | -$11.62M | -$17.19M | -$24.28M | -$24.46M | -$31.81M | -$23.25M | -$13.95M | -$4.95M | -$4.98M |
| Basic EPS | -$1.11 | -$2.31 | -$6.00 | -$9.90 | -$10.20 | -$16.05 | -$15.90 | -$10.50 | -- | -- |
| **Diluted EPS** | -$1.11 | -$2.31 | -$6.00 | -$9.90 | -$10.20 | -$16.05 | -$15.90 | -$10.50 | -- | -- |
| Basic Shares Outstanding | 9.3M | 5.0M | 2.9M | 2.4M | 2.4M | 2.0M | 1.5M | 1.3M | 1.3M | 1.2M |
| Diluted Shares Outstanding | 9.3M | 5.0M | 2.9M | 2.4M | 2.4M | 2.0M | 1.5M | 1.3M | 1.3M | 1.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $523K | $963K | $762K | $852K | $899K | $1.12M | $1.30M | $1.72M |
| **Operating Income** | -$1.61M | -$3.61M | -$2.05M | -$2.24M | -$2.05M | -$2.57M | -$3.09M | -$3.19M |
| **EBITDA** | -$1.59M | -$3.57M | -$2.01M | -$2.20M | -$2.00M | -$2.52M | -$3.04M | -$3.14M |
| **Net Income** | -$1.73M | -$3.85M | -$2.13M | -$2.43M | -$2.11M | -$2.90M | -$2.86M | -$2.97M |
| Basic EPS | -$0.14 | -$0.35 | -$0.19 | -- | -$0.19 | -$0.34 | -$0.45 | -- |
| **Diluted EPS** | -$0.14 | -$0.35 | -$0.19 | -- | -$0.19 | -$0.34 | -$0.45 | -- |
| Basic Shares Outstanding | 12.0M | 11.0M | 11.0M | -- | 11.0M | 8.6M | 6.3M | -- |
| Diluted Shares Outstanding | 12.0M | 11.0M | 11.0M | -- | 11.0M | 8.6M | 6.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $29K | $187K | $1.30M | $772K | $18.86M | $37.83M | $536K | $942K | $2.48M | $547K |
| Short-Term Investments | -- | -- | -- | $2.21M | $3.24M | $4.11M | $33K | $6.12M | $5.27M | $9.44M |
| **Cash & Short-Term Investments** | $29K | $187K | $1.30M | $2.98M | $22.09M | $41.94M | $569K | $7.06M | $7.76M | $9.99M |
| **Total Current Assets** | $307K | $385K | $1.90M | $3.11M | $23.28M | $43.24M | $3.36M | $10.27M | $9.62M | $10.44M |
| Property, Plant & Equipment, Net | $235K | $434K | $686K | $933K | $1.19M | $1.12M | $960K | $651K | $392K | $297K |
| Other Non-Current Assets | $25K | $22K | $2.31M | $5.34M | $6.00M | $8.02M | $3.17M | $958K | $1.80M | $322K |
| **Total Non-Current Assets** | $715K | $1.45M | $2.31M | $5.34M | $6.00M | $8.02M | $3.17M | $958K | $1.80M | $322K |
| **Total Assets** | $1.02M | $1.83M | $4.21M | $8.45M | $29.28M | $51.26M | $6.53M | $11.23M | $11.42M | $10.77M |
| Accounts Payable | $7.07M | $6.08M | $4.95M | $6.22M | $3.70M | $5.42M | $14.68M | $4.55M | $1.42M | $345K |
| Short-Term Debt | $967K | $300K | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | $300K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $11.01M | $8.98M | $7.80M | $8.80M | $6.32M | $11.23M | $17.65M | $6.21M | $5.54M | $864K |
| **Total Non-Current Liabilities** | $0 | $618K | $1.27M | $2.67M | $3.62M | $4.56M | $1.10M | $0 | $0 | $0 |
| **Total Liabilities** | $11.01M | $9.60M | $9.07M | $11.47M | $9.94M | $15.79M | $18.76M | $6.21M | $5.54M | $864K |
| **Total Debt (incl. Leases)** | $1.18M | $1.02M | $1.27M | $4.09M | $5.08M | $7.22M | $2.37M | -- | -- | -- |
| Common Stock | $16K | $14K | $13K | $12K | $12K | $12K | $11K | $11K | $11K | $11K |
| Retained Earnings | -$236.9M | -$226.6M | -$215.0M | -$197.8M | -$173.5M | -$149.1M | -$117.3M | -$94.02M | -$80.08M | -$75.12M |
| **Total Stockholders' Equity** | -$9.98M | -$7.76M | -$4.86M | -$3.02M | $19.34M | $35.46M | -$12.22M | $5.02M | $5.88M | $9.90M |
| Total Equity | -$9.98M | -$7.76M | -$4.86M | -$3.02M | $19.34M | $35.46M | -$12.22M | $5.02M | $5.88M | $9.90M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $163K | $22K | $15K | $29K | $5.0K | $824K | $1.64M | $187K |
| **Cash & Short-Term Investments** | $163K | $22K | $15K | $29K | $5.0K | $824K | $1.64M | $187K |
| **Total Current Assets** | $453K | $316K | $184K | $307K | $508K | $1.51M | $2.33M | $385K |
| Property, Plant & Equipment, Net | $123K | $152K | $198K | $235K | $283K | $331K | $382K | $434K |
| Other Non-Current Assets | -- | -- | -- | $25K | $872K | $1.05M | $1.24M | $22K |
| **Total Non-Current Assets** | $387K | $472K | $571K | $715K | $872K | $1.05M | $1.24M | $1.45M |
| **Total Assets** | $840K | $788K | $755K | $1.02M | $1.38M | $2.57M | $3.57M | $1.83M |
| Accounts Payable | $7.47M | $7.49M | $7.32M | $7.07M | $6.42M | $6.00M | $6.80M | $6.08M |
| Short-Term Debt | $1.88M | $1.26M | $1.33M | $967K | $101K | $101K | $1.20M | $300K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $300K |
| **Total Current Liabilities** | $13.17M | $12.38M | $11.76M | $11.01M | $9.02M | $8.53M | $10.90M | $8.98M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $50K | $95K | $127K | $618K |
| **Total Liabilities** | $13.17M | $12.38M | $11.76M | $11.01M | $9.07M | $8.62M | $11.03M | $9.60M |
| **Total Debt (incl. Leases)** | $1.93M | $1.37M | $1.49M | $1.18M | $427K | $577K | $1.77M | $1.02M |
| Common Stock | $16K | $16K | $16K | $16K | $16K | $16K | $15K | $14K |
| Retained Earnings | -$244.7M | -$242.9M | -$239.1M | -$236.9M | -$234.5M | -- | -$229.5M | -$226.6M |
| **Total Stockholders' Equity** | -$12.33M | -$11.60M | -$11.01M | -$9.98M | -$7.69M | -$6.06M | -$7.46M | -$7.76M |
| Total Equity | -$12.33M | -$11.60M | -$11.01M | -$9.98M | -$7.69M | -$6.06M | -$7.46M | -$7.76M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.31M | -$11.62M | -$17.19M | -$24.28M | -$24.46M | -$31.81M | -$23.25M | -$13.95M | -$4.95M | -$4.98M |
| Depreciation & Amortization | $199K | $240K | $265K | $285K | $260K | $219K | $164K | $110K | $85K | $77K |
| Stock-Based Compensation | $1.52M | $698K | $1.49M | $1.68M | $1.37M | $2.56M | $789K | $1.02M | $616K | $756K |
| Change in Payables | $987K | $1.13M | -$1.27M | $2.52M | -$1.72M | -$9.26M | $10.13M | $3.12M | $1.08M | -$824K |
| **Operating Cash Flow** | -$6.97M | -$9.09M | -$20.46M | -$19.32M | -$26.27M | -$35.19M | -$11.25M | -$12.39M | -$2.36M | -$5.86M |
| Capital Expenditure | -- | -- | -$18K | -$29K | -$330K | -$378K | -$473K | -$369K | -$180K | -$103K |
| **Free Cash Flow** | -- | -- | -$20.48M | -$19.35M | -$26.59M | -$35.57M | -$11.72M | -$12.76M | -$2.54M | -$5.96M |
| **Investing Cash Flow** | -- | $12K | $2.19M | $998K | $323K | -$4.45M | $5.62M | -$1.22M | $3.99M | $5.98M |
| Common Stock Issued | $186.0M | $180.0M | $171K | $151K | $151K | $143K | $64.00M | $59.00M | $46.60M | $0 |
| Share Repurchases | -- | -- | -- | -- | -- | -$116K | -- | -- | -- | -- |
| **Financing Cash Flow** | $6.88M | $7.97M | $18.98M | $238K | $6.97M | $76.94M | $5.22M | $12.06M | $314K | $0 |
| **Net Change in Cash** | -$95K | -$1.11M | $713K | -$18.08M | -$18.97M | $37.29M | -$406K | -$1.54M | $1.94M | $119K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.73M | -$3.85M | -$2.13M | -$2.43M | -$2.11M | -$2.90M | -$2.86M | -$2.97M |
| Depreciation & Amortization | $29K | $46K | $37K | $48K | $48K | $51K | $52K | $53K |
| Stock-Based Compensation | -- | -- | $133K | $143K | $660K | $0 | $717K | $156K |
| Change in Payables | -$15K | $171K | $250K | $647K | $423K | -$800K | $717K | $1.48M |
| **Operating Cash Flow** | -$704K | -$895K | -$1.32M | -$1.19M | -$1.10M | -$3.50M | -$1.63M | -$1.05M |
| Common Stock Issued | -- | $1.0K | $187K | -- | -- | -$181.8B | $182.0B | $2.00M |
| **Financing Cash Flow** | $843K | $898K | $1.25M | $1.23M | $313K | $2.70M | $3.09M | $1.06M |
| **Net Change in Cash** | $139K | $3.0K | -$70K | $40K | -$789K | -$801K | $1.46M | $22K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -126.4% | -89.7% | -- | -278.1% | -84.2% | -50.3% |
| Return on Assets (ROA) | -1008.5% | -634.4% | -408.6% | -287.3% | -83.5% | -62.1% | -355.9% | -124.2% | -43.4% | -46.3% |
| Current Ratio | 0.03x | 0.04x | 0.24x | 0.35x | 3.69x | 3.85x | 0.19x | 1.65x | 1.74x | 12.09x |
| Quick Ratio | 0.00x | 0.02x | 0.17x | 0.34x | 3.50x | 3.73x | 0.03x | 1.14x | 1.40x | 11.56x |
| Debt to Equity | -- | -- | -- | -- | 0.26x | 0.20x | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -1208.2% | -1335.3% | -1267.5% | -1008.5% | -785.9% | -446.1% | -310.4% | -634.4% |
| Current Ratio | 0.03x | 0.03x | 0.02x | 0.03x | 0.06x | 0.18x | 0.21x | 0.04x |
| Quick Ratio | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.10x | 0.15x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
